NCT05258656

Brief Summary

The overall goal of this study is to understand how common conditions in childhood develop and if by providing specific health education and resources to parents/caregivers we can promote healthy development. This study will provide information and instruction on several aspects of infant care including, sleep, nutrition, building a healthy relationship with your baby, and healthy screen time use.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,800

participants targeted

Target at P75+ for not_applicable

Timeline
25mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Mar 2022Jun 2028

First Submitted

Initial submission to the registry

February 11, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

March 3, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

April 27, 2025

Status Verified

April 1, 2025

Enrollment Period

4.2 years

First QC Date

February 11, 2022

Last Update Submit

April 23, 2025

Conditions

Keywords

infant developmenthealth promotion

Outcome Measures

Primary Outcomes (1)

  • One year Assessment

    Caregivers and their child will be asked to attend a research study visit with a physician around the child's 1st birthday that may involve brief examination of the child's skin, surveys about the child's medical history and diet, a supervised feeding of certain common foods, and/or collection of a blood sample.

    ≈12 months of age

Secondary Outcomes (2)

  • Two year assessment

    ≈24 months of age

  • Three year assessment

    ≈36 months of age

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group will receive education about nutrition, resources, and specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.

Behavioral: Intervention

Control

PLACEBO COMPARATOR

The control group will receive specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.

Behavioral: Control

Interventions

InterventionBEHAVIORAL

The intervention group will receive education about nutrition, resources, and specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.

Intervention
ControlBEHAVIORAL

The control group will receive specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.

Control

Eligibility Criteria

AgeUp to 26 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Parent/guardian(s) must understand and provide informed consent
  • Infant \<26 weeks of age at enrollment
  • Willing to be randomized to either intervention or control
  • In good general health as evidenced by medical history
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Child assigned male or female sex at birth

You may not qualify if:

  • Infant completed less than 28 weeks gestation
  • Co-morbid medical diagnoses that would prevent caregivers from initiating solid foods per protocol, such as dysphagia, chronic aspiration, malformations, etc.
  • Co-morbid medical diagnoses that would require specialized diet/nutritional needs, such as congenital heart disease, genetic/metabolic disorders, malignancy, etc.
  • Caregivers who express unwillingness to introduce peanut, milk, egg, or cashew
  • Caregivers who cannot provide informed consent in English or Spanish
  • Parents planning to move away from study sites before child is 12 months of age
  • Infant with a sibling enrolled in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

RECRUITING

Rush University Medical Center

Chicago, Illinois, 60612, United States

RECRUITING

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Ruchi S Gupta, MD MPH

    Northwestern University Feinberg School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

February 11, 2022

First Posted

February 28, 2022

Study Start

March 3, 2022

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2028

Last Updated

April 27, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

We plan to share deidentified, limited data sets and corresponding analytic code with other researchers following the publication of the study data. The protocol, Statistical Analysis Plan, and Informed Consent Forms will also be published online as supplemental appendices and will be made available to other researchers upon request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data and supporting information will be available indefinitely upon their publication.
Access Criteria
Published study datasets will be publicly available. Requests for unpublished data will be reviewed by the PI and advisory board and approved if deemed to have scientific merit.

Locations